SCHOLAR ROCK HOLDING CORPORATION Increase (Decrease) in Other Noncurrent Liabilities
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Increase (Decrease) in Other Noncurrent Liabilities of $57.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2025-08-06
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $36.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2025-03-31 was $21.00K, a 0.00% change year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2024-12-31 was $2.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for the quarter ending 2024-09-30 was -$12.00K, a 150.00% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$114.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$138.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$8.00K, a 103.51% decline from fiscal 2021.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent liabilities for fiscal 2021 was $228.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $57.00K 10-Q · filed 2025-08-06 | $59.00K derived: sum of 3 quarters · filed 2025-08-06 | $47.00K derived: sum of 4 quarters · filed 2025-08-06 | |
| 2025-03-31 | $21.00K 10-Q · filed 2025-05-14 | $23.00K derived: sum of 2 quarters · filed 2025-05-14 | $11.00K derived: sum of 3 quarters · filed 2025-05-14 | -$114.00K derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$10.00K derived: sum of 2 quarters · filed 2025-02-27 | -$135.00K derived: sum of 3 quarters · filed 2025-08-06 | -$114.00K 10-K · filed 2025-02-27 | |
| 2024-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$137.00K derived: sum of 2 quarters · filed 2025-08-06 | -$116.00K 10-Q · filed 2024-11-12 | -$196.00K derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$104.00K 10-Q · filed 2025-08-06 | -$184.00K derived: sum of 3 quarters · filed 2025-08-06 | -$160.00K derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-14 | -$59.00K derived: sum of 2 quarters · filed 2025-05-14 | -$35.00K derived: sum of 3 quarters · filed 2025-05-14 | -$15.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$56.00K derived: sum of 2 quarters · filed 2025-02-27 | -$36.00K derived: sum of 3 quarters · filed 2025-02-27 | -$138.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $44.00K derived: sum of 2 quarters · filed 2024-11-12 | -$58.00K 10-Q · filed 2024-11-12 | $161.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$82.00K 10-Q · filed 2024-08-08 | $137.00K derived: sum of 3 quarters · filed 2024-08-08 | $141.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$102.00K 10-Q · filed 2024-05-07 | $117.00K derived: sum of 2 quarters · filed 2024-05-07 | $121.00K derived: sum of 3 quarters · filed 2024-05-07 | -$124.00K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $223.00K derived: sum of 2 quarters · filed 2024-03-19 | -$22.00K derived: sum of 3 quarters · filed 2024-03-19 | -$8.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$241.00K derived: sum of 2 quarters · filed 2023-11-07 | -$227.00K 10-Q · filed 2023-11-07 | -$226.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$231.00K 10-Q · filed 2023-08-09 | -$230.00K derived: sum of 3 quarters · filed 2023-08-09 | -$230.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $14.00K 10-Q · filed 2023-05-09 | $15.00K derived: sum of 2 quarters · filed 2023-05-09 | $15.00K derived: sum of 3 quarters · filed 2023-05-09 | $19.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $1.00K derived: sum of 2 quarters · filed 2023-03-07 | $5.00K derived: sum of 3 quarters · filed 2023-03-07 | $228.00K 10-K · filed 2023-03-07 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.00K derived: sum of 2 quarters · filed 2022-11-14 | $227.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $227.00K 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $223.00K 10-Q · filed 2022-05-16 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-09 | -$72.00K derived: sum of 3 quarters · filed 2021-03-09 | -$59.00K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$72.00K derived: sum of 2 quarters · filed 2020-11-09 | -$59.00K 10-Q · filed 2020-11-09 | -$46.00K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$59.00K 10-Q · filed 2020-08-07 | -$46.00K derived: sum of 3 quarters · filed 2020-08-07 | -$33.00K derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | $13.00K 10-Q · filed 2020-05-07 | $26.00K derived: sum of 2 quarters · filed 2020-05-07 | $39.00K derived: sum of 3 quarters · filed 2020-05-07 | $88.00K derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $26.00K derived: sum of 2 quarters · filed 2020-03-12 | $75.00K derived: sum of 3 quarters · filed 2020-03-12 | $108.00K 10-K · filed 2020-03-12 | $52.00K 10-K · filed 2019-03-19 |
| 2018-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $62.00K derived: sum of 2 quarters · filed 2019-11-12 | $95.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $82.00K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $33.00K 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | $46.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |